Hemafuse Used in First Planned Orthopedic Surgery 

April 9, 2019  

BALTIMORE, Maryland 09 April, 2019  – Hemafuse was successfully used in the first planned orthopedic surgery. Hemafuse is a cutting-edge medical device that can be used to autotransfuse a patient’s blood in situations where there are no other options, and now, as the preferred option over donor blood. There is a significant shortage of donor blood seen across Africa and around the world. When a hospital has an insufficient blood supply, scheduled surgeries are often delayed or cancelled, increasing comorbidities and fatalities.

Hemafuse introduces an alternative to donor blood in both emergency and planned surgeries, because your own blood is better than someone else’s.

About Sisu Global: Sisu Global is a corporation headquartered in Baltimore, Maryland. We envision a world where medical technology enables access to healthcare in every community. Right now, 80% of the world’s medical devices are designed for 10% of the world’s population. Sisu aims to change this statistic by designing and scaling medical devices made specifically for the global market. Sisu is the manufacturer of goods including the HEMAFUSE™ System. The HEMAFUSE™ is a device that can support the donor blood ecosystem by providing an option for clinicians to salvage and recycle a patient’s own blood in cases of internal bleeding. This immediate access to blood can shorten the wait time to perform surgery, increase hospital efficiency and provide access to blood where there may be no other option.

Sisu Global’s work has received numerous features such as CBS 60 Minutes, USA Today, Smithsonian.com and awards from GE Healthcare, USAID, the Gates Foundation, and many others. Sisu has presented at scientific and international conferences across the globe.  For more information, please visit our website, https://sisuglobal.health

About HEMAFUSE™: The HEMAFUSE™ is a handheld, mechanical medical device for intraoperative autotransfusion of blood collected from an internal hemorrhage, meant to replace or augment donor blood in emergency situations.  The HEMAFUSE™ is a device that can support the donor blood ecosystem by providing an option for clinicians to salvage and recycle a patient’s own blood in cases of internal bleeding. This immediate access to blood can shorten the wait time to perform surgery, increase hospital efficiency and provide access to blood where there may be no other option.